Compare SEIC & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEIC | FMS |
|---|---|---|
| Founded | 1968 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 13.6B |
| IPO Year | 1995 | 2005 |
| Metric | SEIC | FMS |
|---|---|---|
| Price | $104.83 | $22.41 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | ★ $104.86 | $30.00 |
| AVG Volume (30 Days) | ★ 701.0K | 619.3K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | 1.14% | ★ 2.57% |
| EPS Growth | ★ 27.66 | N/A |
| EPS | ★ 2.99 | N/A |
| Revenue | ★ $2,297,381,000.00 | N/A |
| Revenue This Year | $14.61 | N/A |
| Revenue Next Year | $7.25 | $3.83 |
| P/E Ratio | $34.76 | ★ $15.62 |
| Revenue Growth | ★ 8.10 | N/A |
| 52 Week Low | $75.08 | $20.02 |
| 52 Week High | $112.15 | $27.64 |
| Indicator | SEIC | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | N/A |
| Support Level | $86.62 | N/A |
| Resistance Level | $107.00 | N/A |
| Average True Range (ATR) | 2.06 | 0.00 |
| MACD | -0.78 | 0.00 |
| Stochastic Oscillator | 18.11 | 0.00 |
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2025, SEI (including LSV) manages, administers, or advises about $1.9 trillion in assets.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.